- Projects & figures
- News & Events
- Managing your project
- About ERC
Until recently, lungs were believed to be sterile, but today we know that they are inhabited by microbes migrating from the mouth. Dr Randi Bertelsen has been awarded an ERC grant to investigate the role played by the oral microbiome in lung disease.
In only three years’ time, Dr Jan Tkač went from being the first ERC grantee in Slovakia to obtaining the “2015 Scientist of the Year” award. His research in the field of glyconomics could emerge as a turning point for the diagnosis of cell-related diseases.
The use and misuse of antibiotics has accelerated the emergence of drug-resistant bacterial strains, threatening our ability to treat common diseases. EU-funded research has shed new light on the mechanisms behind these microbial mutations, with implications for our understanding of diseases and resistance to treatment.
Regulating migration has become a key priority for European countries and, according to Prof. Katja Franko, crime control practices and penal cultures have evolved across the continent as a consequence. With ERC support, she has studied these new hybrid and intertwined forms of migration and crime control policies, a phenomenon she calls ‘Crimmigration control’.
Maria Brandão de Vasconcelos, together with her colleague Filipa Matos Baptista, Henrique Veiga-Fernandes (ERC grantee), Diogo Fonseca Pereira and Sílvia Arroz Madeira, founded StemCell2MAX in 2015. The company is a biotechnology start-up, specialised in cell based therapies, including novel solutions to multiply the scarcely available blood stem cells, addressing an enormous demand for research and cancer treatment. StemCell2MAX technology is based on Prof. Veiga-Fernandes's ground-breaking discoveries in hematopoietic stem cell biology.
Originally published in March 2017 as part of the multimedia campaign "ERC - 10 years – 10 portraits."
Haematopoietic Stem Cells (HSCs) are blood cells located in the bone marrow. These cells are extensively used in research to develop treatments for many severe diseases, including HIV and multiple sclerosis, and their transplant is a key therapy for certain types of cancer like leukemia and multiple myeloma. However, the use of HSCs is seriously constrained by their limited availability since growing them in the lab does not produce very large quantities. There is therefore an urgent need for methods allowing scientists to multiply HSCs, without losing any of their properties.
ERC grantee Marta Moita and her team use cutting-edge experimental procedures to investigate how rats and flies learn to appropriately respond to danger from other individuals. The results of her study may teach us a lot about our own brains, and shed light on diseases that impair social behaviour.
In Bratislava, the team of Dr Ján Tkáč is developing the weapons to fight back in a cellular ‘cold war’ by using new early-detection technologies – helped by the first ERC grant awarded in Slovakia. Glycans are sugar molecules that carry the information human cells need to stay healthy and fight infections. Information rich, and with sophisticated storage and coding commands, they are a vital early-warning system for triggering an organism’s natural defensive systems at the first sign of attack. So it is not surprising that infectious pathogens such as bacteria and viruses, and cell-related diseases such as cancers, have developed subterfuges to bypass this first line of defence. For example, HIV viruses do this by cracking the glycan’s molecular code, and stealing its identity – allowing the pathogen to go unrecognised by cells until the infection is well advanced.
Pursuing a sustainable development and broadening social justice and cohesion are some of the challenges that Europe is currently facing. What if we could learn how to solve these challenges by using the social and political innovations taking place in different corners of the globe? Professor Boaventura de Sousa Santos suggests that a new approach can be developed in Europe based on the diversity of practices elsewhere.
Forget USA, Japan; the field of transparent electronics has put Portugal well and truly on the map thanks to Professor Elvira Fortunato and one of the largest grants awarded to a Portuguese scientist. The European Research Council grant contributed to the installation of the recently opened NOVA Nano-Fabrication Laboratory, of which Prof Fortunato is the Director.